GENMAB A/S

Genmab is a cutting edge SME (approximately 200 employees) that has access to unique technology of fully human monoclonal antibodies (via immunisation of transgenic animals expressing human immunoglobulin genes). The company is presently developing the first generation of fully human antibodies for therapeutic use (IL-15, CD20 and TAC). Using its technology, the company will be ideally suited to develop targeted therapies against a series of new target molecules that will be identified within the present consortium. The company's headquarters is in Copenhagen , Denmark . The work with AUTOCURE will be conducted at the Dutch subsidiary in Utrecht .

Contact

Name	Paul Parren
Phone	+ 31 30 2123 108
Fax	+ 31 30 2123 196
E-mail	p.parren@nl.genmab.com